# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-22-029906
Filing Date
2022-11-14
Accepted
2022-11-14 17:11:50
Documents
60
Period of Report
2022-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | cpix-20220930.htm iXBRL | 10-Q | 1138192
2 | EX-10.1 | pinnaclebank-cpiamend9tolo.htm | EX-10.1 | 12037
3 | EX-31.1 | a2022q3-exhibit311.htm | EX-31.1 | 12647
4 | EX-31.2 | a2022q3-exhibit312.htm | EX-31.2 | 12641
5 | EX-32.1 | a2022q3-exhibit321.htm | EX-32.1 | 6984
11 |  | image_1.jpg | GRAPHIC | 32235
12 |  | image_2.jpg | GRAPHIC | 29543
| Complete submission text file | 0001628280-22-029906.txt |  | 4994288

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
6 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | cpix-20220930.xsd | EX-101.SCH | 34059
7 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | cpix-20220930_cal.xml | EX-101.CAL | 55204
8 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | cpix-20220930_def.xml | EX-101.DEF | 137444
9 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | cpix-20220930_lab.xml | EX-101.LAB | 412993
10 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | cpix-20220930_pre.xml | EX-101.PRE | 272032
54 | EXTRACTED XBRL INSTANCE DOCUMENT | cpix-20220930_htm.xml | XML | 707745

Mailing Address 2525 WEST END AVENUE SUITE 950 NASHVILLE TN 37203
Business Address 2525 WEST END AVENUE SUITE 950 NASHVILLE, TN 37203 615-255-0068
CUMBERLAND PHARMACEUTICALS INC (Filer) CIK: 0001087294 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33637 | Film No.: 221387544
SIC: 2834 Pharmaceutical Preparations